Skip to main
GEHC
GEHC logo

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

GE HealthCare Technologies has exhibited a robust growth trajectory indicated by a backlog that is now approximately $1 billion above pre-COVID levels, driven by consistent low-to-mid single-digit order growth and a favorable book-to-bill ratio above 1. The company reported a commendable gross margin of 41.4% in the fourth quarter, exceeding expectations due to improved volumes and a higher mix of new products at advantageous pricing, alongside a notable increase in revenue from the patient diagnostics segment, which surged 24% year-over-year. Additionally, the sustained growth in EBIT margins, which rose by 50 basis points year-over-year to 15.3% in the second quarter of 2024, reflects effective pricing strategies and operational efficiencies, underpinning confidence in the financial stability and future performance of GE HealthCare Technologies.

Bears say

GE HealthCare Technologies has faced notable challenges due to declining sales in China, with year-over-year decreases of approximately 11% and 18% reported in the first and second quarters of 2024 respectively. The company has adjusted its full-year 2024 sales guidance downward by about $500 million to reflect ongoing pressures, including volume-based procurement and reduced capital spending by hospitals in the region. Furthermore, despite a book-to-bill ratio of 1.03 in the third quarter indicating a healthy order intake, the overall top-line performance in the first half of 2024 was negatively impacted, leading to a cautious outlook for the remainder of the year.

GEHC has been analyzed by 16 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 16 analysts, GEHC has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.